Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: Correlations with serum troponin I

Clinical Cardiology

Volumn 28, Issue 4, 2005, Pages 182-186

  Manginas, Athanassios ^a   Bei, Evgenia ^a   Chaidaroglou, Antigoni ^a   Degiannis, Dimitrios ^a   Koniavitou, Katerina ^a   Voudris, Vassilis ^a   Pavlides, Gregory ^a   Panagiotakos, Demosthenis ^a,b   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Acute coronary syndrome; Inflammation; Matrix metalloproteinase 9; Troponin

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 16344367552     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280405     Document Type: Article

References (19)

1. Dolley CM, McEvan JR, Henney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-868
2. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 1998;10:602-608
3. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Rengstrom J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Circulation 1995;92:1565-1569
4. Li YY, McTieman CF, Feldman AM: Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000;46:214-224
5. Haft JI, Mariano DL, Goldstein J: Comparison of the histopathology of culprit lesions in chronic stable angina, unstable angina, and myocardial infarction. Clin Cardiol 1997;20:651-655
6. Braunwald E, Amman EM, Beasley JW, Calliff RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Théroux P, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC: ACC/AHA 2002 guidelines update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. A report of the ACC/AHA Task Force on practice guidelines (Committee on the management of patients with unstable angina). J Am Coll Cardiol 2002;40 Available at: http://www.acc.org
7. Braunwald E: Unstable angina: A classification. Circulation 1989;80:410-414
8. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuahara F, Ueno T, Sugi K, Imaizzumi T: Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998;32:368-372
9. Inocubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K: Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001;141:211-217
10. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT: Macrophage infiltration in acute coronary syndromes. Circulation 1994;90:775-778
11. Tziakas DN, Chalikias GK, Parissis JT, Hatzinikolaou EI, Papadopoulos ED, Tripsiannis GA, Papadopoulou EG, Tentes IK, Karas SM, Chatseras DI: Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. Int J Cardiol 2004;94:269-277
12. Nomoto K, Ogushi S, Watanabe I, Kushiro T, Kanmatsutse K: Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 2003;42:201-206
13. Moukarbel GV, Arnaout MS, Alam SE: C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina. Clin Cardiol 2001;24:506-510
14. Rajavashist TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, Shah PK: Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory cytokines. Circulation 1999;99:3103-3109
15. Saren P, Welgus HG, Kovanen PT: TNF-a and IL-1b selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996;157:4159-4165
16. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Moanco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877
17. Rader DJ: Inflammatory markers of coronary risk. N Engl J Med 2000;343:1179-1182
18. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR: Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Colt Cardiol 2002;39:1917-1923
19. Mazzone A, De Servi S, Mazzucchelli I, Bossi I, Vezzoli M, Meloni F, Lotzinker M, Mariani G: Increased concentrations of inflammatory mediators in unstable angina: Correlation with serum troponin T. Heart 2001;85:571-575